Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 72319-021

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 72319-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemicalstructure)

FDA Label Image

Container-1000mg-60tablets (Container 1000mg 60tablets)

Manufacturer: i3 Pharmaceuticals. Product name: Ranolazine ERSET Extended-Release Tablets, strength: 193 mg. Packaging: 60 Tablets. This description provides basic information about the medication and its manufacturer, as well as dosage strength and packaging.*

FDA Label Image

Container-500mg-60tablets (Container 500mg 60tablets)

This appears to be a pharmaceutical drug information sheet. The name of the drug is Ranolazine, which is in the form of extended-release tablets. The sheet also includes the manufacturer's name, Ecnmmoons aorke and the Rk NoC 7231902102. There is information about the standard dosage and package size. Additionally, there is a reference code at the end of the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.